Fractyl Health, Inc. - Common Stock — 현금 흐름 (NASDAQ:GUTS)

Financials

영업활동으로 인한 현금 -65.52 M-90.33 M -87.73 M 투자 활동으로 인한 현금 -1.76 M-557 K — 재무활동으로 인한 현금 101.23 M104.96 M 108.89 M 잉여 현금 흐름 -65.52 M-90.89 M -87.83 M

Fractyl Health, Inc. - Common Stock

Fractyl Health is a Burlington, Massachusetts-based healthcare company focused on metabolic diseases like obesity and type 2 diabetes. The company developed Revita, an outpatient endoscopic procedure to modify duodenal dysfunction, and Rejuva, a gene therapy platform in preclinical development to enable the pancreas to produce glucagon-like peptide-1.

GUTS

Financials

Fractyl Health, Inc. - Common Stock

뉴스

Fractyl Health, Inc. (GUTS) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Fractyl Health, Inc. (GUTS) Q1 2026 Earnings Call Transcript

Fractyl Health, Inc. (GUTS) Q4 2025 Earnings Call Transcript

Fractyl Health, Inc. (GUTS) Loses 77.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Fractyl Health: Low Market Expectations Create Trading Opportunity With 2026 Catalysts

모건 스탠리, Fractyl Health 투자의견 ’동일 비중’으로 하향

Morgan Stanley downgrades Fractyl Health stock rating to Equalweight on Revita trial results

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.11%

Why Is Fractyl Health Stock Tumbling Today? - Fractyl Health (NASDAQ:GUTS)

Fractyl Health, GLP-1 체중 유지 데이터 발표 후 급락

Revita, GLP-1 중단 후 체중 유지에 효과 보여

Fractyl Health stock falls after midpoint data on GLP-1 weight maintenance